A federal court injunction issued on Monday curtailed several of Health Secretary Robert F. Kennedy Jr.'s most significant alterations to U.S. vaccine policy, but physicians and public health officials warned the controversy that preceded the order has already harmed public trust and could be hard to reverse.
U.S. District Judge Brian Murphy found that Kennedy acted improperly when he dismissed all 17 independent public health and infectious disease vaccine advisers and then installed a new Advisory Committee on Immunization Practices - ACIP - with 15 hand-picked members. In his ruling the judge observed that most of those appointees appear "distinctly unqualified," and said the committee had been unlawfully reconstituted.
The legal action, filed by the American Academy of Pediatrics and other plaintiffs, reverses several of Kennedy's moves intended to reshape routine childhood vaccination recommendations - including steps that reduced the number of shots broadly recommended for children. The injunction could, however, be temporary if the government chooses to appeal.
Experts who had warned for months that the administration's rapid changes would destabilize vaccine policy said those warnings have been borne out in public sentiment and state responses. Michael Osterholm, director of the University of Minnesota's Center for Infectious Disease Research and Policy, summed up the challenge: "The genie is out of the bottle. We're going to have to live with that."
Policy shifts that bypassed established processes
Over the past year, Kennedy implemented vaccine policy changes that frequently sidestepped the government’s traditional, evidence-based recommendation process. At the reconstituted panel’s September meeting, advisers voted to remove a routine recommendation for COVID vaccines and instead advised that individuals consult their doctor - a practice known as shared clinical decision-making.
At the panel’s December meeting, the group voted to abandon a longstanding recommendation for universal newborn hepatitis B vaccination - a policy the article notes had been shown to reduce hepatitis B infections in children by 99% - and did so without providing scientific evidence to justify the change.
In January, Kennedy narrowed the federal childhood vaccine schedule, again without full panel input or demonstrable scientific support, and moved four previously routine shots to shared clinical decision-making. The Centers for Disease Control and Prevention subsequently recommended 11 vaccines broadly, down from 17 under the prior schedule.
Public health specialists underscored that parents have always had the option to discuss vaccination with their physicians. Still, shifting vaccines from routine recommendations to shared decision-making can create uncertainty about safety, Osterholm said: "It creates doubt if you now have to discuss it with your doctor."
State governments and professional societies push back
The policy changes prompted swift reactions from states and professional medical organizations. According to a poll by the nonprofit health policy organization KFF, as of March 10 some 30 states, including the District of Columbia, said they would not follow the CDC’s new recommendations for at least certain childhood vaccines. Of that group, 27 states said they would not rely on CDC guidance for any childhood vaccines.
Most of those states indicated they would instead adhere to recommendations from the American Academy of Pediatrics, which has published vaccine guidance since the 1930s. Historically the AAP had aligned its schedule with federal advice, but last year it broke from that practice, stating that ACIP’s process was "no longer credible."
Richard Hughes IV, lead counsel for the American Academy of Pediatrics, acknowledged the court victory but said the disruption had already caused damage. The legal challenge, he said, was required to "stop the continued destruction of science‑based policy for vaccines."
A Department of Health and Human Services spokesperson reacted to the ruling by saying, "HHS looks forward to this judge’s decision being overturned."
Former agency officials and clinicians raise alarm
Several former and departing agency officials had publicly protested the policy shift. Dr. Demetre Daskalakis, who left the Centers for Disease Control and Prevention in August along with three others in opposition to Kennedy’s vaccine actions, said he was pleased the legal challenge drew attention to the issue and stressed the need to repair the damage and control disease propagation: "Now we need to repair the damage these HHS actions have caused and the disease that they have allowed to propagate."
Front-line pediatricians and clinic staff report that the policy swings have left parents confused and asking whether even routine newborn interventions, such as vitamin K, remain advisable. Providers are hearing increased uncertainty from families, Alison Barkoff, a health law and policy expert at George Washington University who joined an amicus brief supporting the AAP, said.
A KFF poll from February found that trust in the CDC as a source of reliable vaccine information is at its lowest point since the start of the COVID-19 pandemic. Jen Kates, a senior analyst at KFF, cautioned that a court-ordered reset cannot instantly erase months of politicized debate: "It’s not like you can flip a switch and say, 'OK, let’s go back to where we were.'"
Implications and next steps
The court order effectively restores the legal and procedural framework that had guided vaccine recommendations, but it leaves open the possibility of further legal contest if the Department of Health and Human Services appeals. Meanwhile, the split between federal guidance and state-level actions has already resulted in substantial variation in which schedules will be followed across the country.
Health officials and pediatric groups say reversing the erosion of public confidence will require time and consistent, evidence-based communication. The court ruling halts the immediate trajectory of Kennedy’s changes, but experts emphasize that rebuilding trust and reestablishing uniform policy adherence are longer-term challenges.
For now, parents, clinicians and state health systems must navigate conflicting guidance and the lingering consequences of months of disrupted policy and public debate.